Human Lymphatic Endothelial Cells Expressing NRAS<sup>Q61R</sup> Model Characteristics of Kaposiform Lymphangiomatosis

Kaposiform lymphangiomatosis (KLA) is a complex lymphatic anomaly characterized by lymphatic overgrowth and dysfunction. The goal of this study was to determine how the NRAS<sup>Q61R</sup> variant found in the tissue of KLA patients impacts key characteristics of lymphatic endothelial cells (LEC). LEC expressing NRAS<sup>Q61R</sup> had a spindled morphology, increased migration, increased proliferation, increased MAPK signaling, and elevated angiopoietin-2 production. In an in vitro lymphangiogenesis model, LEC expressing NRAS<sup>Q61R</sup> showed increased sprouting and formed enlarged and disorganized vascular structures. This model of LEC expressing NRAS<sup>Q61R</sup> can be used to give insights into KLA pathogenesis and test new treatments.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-08-18
DOI
https://doi.org/10.1002/pbc.31984
Citations
1
Primary Topic
Vascular Malformations and Hemangiomas
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human Lymphatic Endothelial Cells Expressing NRASQ61R Model Characteristics of Kaposiform Lymphangiomatosis

Timothy D. Le Cras, C. Griffin McDaniel, Patricia Pastura, Dermot Fox
1 citations
Pediatric Blood & Cancer
Vascular Malformations and Hemangiomas
2.01
article

Human Lymphatic Endothelial Cells Expressing NRASQ61R Model Characteristics of Kaposiform Lymphangiomatosis

Timothy D. Le Cras, C. Griffin McDaniel, Patricia Pastura, Dermot Fox
article en
1 citations

Abstract

Kaposiform lymphangiomatosis (KLA) is a complex lymphatic anomaly characterized by lymphatic overgrowth and dysfunction. The goal of this study was to determine how the NRAS<sup>Q61R</sup> variant found in the tissue of KLA patients impacts key characteristics of lymphatic endothelial cells (LEC). LEC expressing NRAS<sup>Q61R</sup> had a spindled morphology, increased migration, increased proliferation, increased MAPK signaling, and elevated angiopoietin-2 production. In an in vitro lymphangiogenesis model, LEC expressing NRAS<sup>Q61R</sup> showed increased sprouting and formed enlarged and disorganized vascular structures. This model of LEC expressing NRAS<sup>Q61R</sup> can be used to give insights into KLA pathogenesis and test new treatments.

Pediatric Blood & CancerVol. 72(11)
Cincinnati Children's Hospital Medical Center (US)
National Institutes of Health
Openalex Percentile: Top 12%
Vascular Malformations and Hemangiomas
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.